Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BF-200 ALA (Ameluz) PDT for Actinic Keratosis
NCT02799082Phase 3Completed
- Sponsor
- Biofrontera
- Start
- Dec 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by Biofrontera. Started Dec 2007; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02799082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799082.